Literature DB >> 16928350

Autoimmune optic neuropathy.

James Goodwin1.   

Abstract

The subjects of this review are the various types of optic nerve disease that involve autoimmune mechanisms, broadly defined. These include optic neuropathy caused by direct inflammatory involvement of the nerve parenchyma and optic nerve damage as an ischemic sequel to primary vasculitis, although there is naturally some overlap between the two conditions. The review considers 1) optic neuropathy that occurs as part of recognized systemic autoimmune disorders and collagen vascular diseases; and 2) isolated autoimmune optic neuropathy in which there is usually some serologic marker indicating the autoimmune nature of the process but without the signs or symptoms of a systemic disease and without the standard criteria for diagnosing a specific systemic disease.

Entities:  

Mesh:

Year:  2006        PMID: 16928350     DOI: 10.1007/s11910-996-0020-0

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  27 in total

1.  Microscopic polyangitis presenting with sub-acute reversible optic neuropathy.

Authors:  R Altaie; F Ditizio; G T Fahy
Journal:  Eye (Lond)       Date:  2005-03       Impact factor: 3.775

2.  Anterior ischaemic optic neuropathy secondary to Henoch-Schönlein Purpura.

Authors:  J Chuah; T Meaney
Journal:  Eye (Lond)       Date:  2005-09       Impact factor: 3.775

3.  Successful high dose glucocorticoid treatment for subacute neuromyelitis optica with systemic lupus erythematosus.

Authors:  Noriko Hagiwara; Kazunori Toyoda; Takeshi Uwatoko; Kotaro Yasumori; Setsuro Ibayashi; Yasushi Okada
Journal:  Intern Med       Date:  2005-09       Impact factor: 1.271

4.  Autoimmune optic neuropathy: evaluation and treatment.

Authors:  M J Kupersmith; R M Burde; F A Warren; T G Klingele; L P Frohman; H Mitnick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-11       Impact factor: 10.154

5.  Bilateral optic neuritis in wegener granulomatosis.

Authors:  Mário Luiz Ribeiro Monteiro; Wander Inturias Sergillo Borges; Carolina do Val Ferreira Ramos; Leandro Tavares Lucato; Cláudia Costa Leite
Journal:  J Neuroophthalmol       Date:  2005-03       Impact factor: 3.042

6.  Anterior ischemic optic neuropathy in Churg-Strauss syndrome.

Authors:  J C Kattah; G A Chrousos; P A Katz; B McCasland; M P Kolsky
Journal:  Neurology       Date:  1994-11       Impact factor: 9.910

7.  Neurologic manifestations of Churg-Strauss syndrome.

Authors:  M Sehgal; J W Swanson; R A DeRemee; T V Colby
Journal:  Mayo Clin Proc       Date:  1995-04       Impact factor: 7.616

8.  Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients.

Authors:  Sophie Delalande; Jérôme de Seze; Anne-Laure Fauchais; Eric Hachulla; Tanya Stojkovic; Didier Ferriby; Sylvain Dubucquoi; Jean-Pierre Pruvo; Patrick Vermersch; Pierre-Yves Hatron
Journal:  Medicine (Baltimore)       Date:  2004-09       Impact factor: 1.889

9.  Churg-Strauss syndrome (allergic granulomatous angiitis). Neuro-ophthalmologic manifestations.

Authors:  J M Weinstein; H Chui; S Lane; J Corbett; J Towfighi
Journal:  Arch Ophthalmol       Date:  1983-08

10.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

View more
  5 in total

1.  Diversity in autoimmunity against retinal, neuronal, and axonal antigens in acquired neuro-retinopathy.

Authors:  Grazyna Adamus; Lori Brown; Jade Schiffman; Alessandro Iannaccone
Journal:  J Ophthalmic Inflamm Infect       Date:  2011-07-10

2.  Successful Combination Therapy with Rituximab and Glucocorticoids for Autoimmune Optic Neuropathy.

Authors:  Shoichi Sasaki; Daisuke Asahara; Kaichi Kaneko; Satoru Komatsumoto
Journal:  Am J Case Rep       Date:  2015-06-09

Review 3.  Diversified Treatment Options of Adult Stem Cells for Optic Neuropathies.

Authors:  Shaoying Tan; Yao Yao; Qichen Yang; Xiang-Ling Yuan; Ling-Ping Cen; Tsz Kin Ng
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

4.  Current options for the treatment of optic neuritis.

Authors:  John H Pula; Christopher J Macdonald
Journal:  Clin Ophthalmol       Date:  2012-07-31

5.  Demyelinizing Neurological Disease after Treatment with Tumor Necrosis Factor-α Antagonists.

Authors:  Claudia Bruè; Cesare Mariotti; Ilaria Rossiello; Andrea Saitta; Alfonso Giovannini
Journal:  Case Rep Ophthalmol       Date:  2016-07-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.